Riskpilot← Back to searchSign inGet full accessNAMSOS FYSIOTERAPI AS
ASActiveOrg 998870275Kirkegata 14, 7800 NamsosPhysiotherapy activities · NACE 8695Est. 20123 employeeswww.namsosfysioterapi.no
Revenue 2024
NOK 1,7M
+5% vs 2023
EBITDA margin
12.0%
+85% vs 2023
Equity ratio
25.0%
Financial strength
Net profit 2024
NOK 148K
+156% vs 2023
| Revenue | NOK 1,7M | +5% |
| EBITDA | NOK 205K | +85% |
| Net profit | NOK 148K | +156% |
| Total assets | NOK 449K | +7% |
| Equity | NOK 112K | -2% |
| Employees | 3 | — |
Legal name
NAMSOS FYSIOTERAPI AS
Org number
998870275
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
24. september 2012
Share capital
NOK 60 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Fysioterapitjenester og salg av andre helserelaterte produkter
Address
Kirkegata 14, 7800 Namsos
Phone
+4799644373
Website
www.namsosfysioterapi.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 574 | 1 610 | 1 505 | 1 630 | 1 712 |
| Staff expenses | −1 101 | −1 015 | −1 046 | −1 232 | −1 147 |
| EBITDA | 144 | 219 | 153 | 111 | 205 |
| Depreciation & amort. | −38 | −38 | −48 | −31 | −18 |
| EBIT | 106 | 181 | 105 | 80 | 187 |
| Net financials | 2 | 41 | −0 | −2 | −0 |
| Profit before tax | 108 | 222 | 105 | 78 | 187 |
| Tax | 24 | 49 | −11 | 21 | 39 |
| Net profit | 84 | 173 | 115 | 58 | 148 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 669 | 771 | 377 | 418 | 449 |
| Equity | 418 | 91 | 106 | 114 | 112 |
| Long-term debt | 11 | 42 | 0 | 0 | 0 |
| Short-term debt | 240 | 638 | 270 | 304 | 337 |
| Total debt | 251 | 680 | 270 | 304 | 337 |
EBITDA margin
12.0%
This company
15.8%
Market median
-24% vs market
20202024
Equity ratio
25.0%
This company
38.2%
Market median
-35% vs market
20202024
Return on equity
131.9%
This company
18.4%
Market median
+617% vs market
20202024
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
20202024
Asset turnover
3.81×
This company
1.12×
Market median
+240% vs market
20202024
Debt / equity
3.01×
This company
0.62×
Market median
-385% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PA Accountant | Accountant | 2012 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2026 | |
| Chairman | 2012 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Selwåg Investments As
NAMSOS FYSIOTERAPI AS Board members of NAMSOS FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pål Arve Risvik | Accountant | 0 companies |
| Eirik Wågan Selnes | Board of Directors | 0 companies |
| Steffen Hammer Selnes | Chairman | 0 companies |
| Vetle Wågan Selnes | Board of Directors | 0 companies |
| Ann-Kristin Evensen Wågan | Board of Directors | 0 companies |